华润双鹤控股子公司双鹤天安通过GMP符合性检查

Core Viewpoint - China Resources Double Crane Pharmaceutical (600062.SH) announced that its subsidiary, Double Crane Tianan Pharmaceutical (Guizhou) Co., Ltd., received a GMP compliance inspection notice from the Guizhou Provincial Drug Administration [1] Group 1: Company Developments - The inspection notice (No. 黔20250059) pertains to the production of Metformin and Ertugliflozin tablets (Ⅰ), with each tablet containing 500mg of Metformin Hydrochloride and 5mg of Ertugliflozin [1] - The production line involved in the inspection is designed with an annual capacity of 500 million tablets [1]